Clinical trial
ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients…
NCT00334828 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00334828 |
|---|---|
| Title | ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis |
| Official title | ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Severe Sepsis |
| Intervention type | Drug |
| Interventions | eritoran tetrasodium, Placebo |
| Enrollment | 2,000 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2011 |
| First posted | Jun 8, 2006 |
| Last update posted | Jul 25, 2017 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Hong Kong, Israel and 12 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: